Active SanctionorganizationID: trade-csl-7e3c3cbd0366d0f705b9121480fb53637efc6f028b91dab56b46592f

Wuhan Institute of Biological Products Co., Ltd.

Primary Source
US TRADE CSL
Coverage
cn
Risk Tier
Critical
Last Updated
2026-07-26

Compliance Profile

"Risk Advisory: Records indicate that Wuhan Institute of Biological Products Co., Ltd. is associated with US TRADE CSL. Source-list verification is recommended."

Banking Impact

Due to designation on US TRADE CSL, processing any financial operations for this counterparty poses severe compliance risks, including secondary sanctions and asset forfeiture.

Legal Status

Strict embargo applies to commercial engagement. Any attempted contracts or supply chain interactions must be scrutinized against statutory prohibitions.

Official Source Metadata

Source: Multi-Source Risk Profile
Full Legal NameWuhan Institute of Biological Products Co., Ltd.
Source Records
US TRADE CSL
Enforcement TypeMulti-Source Risk Profile
Risk Topicssanction, export.control, maritime

Compliance Context Review

Independent Risk Assessment

SIC Group prepares source-backed risk context, exposure memos, and remediation pathways for entities seeking to clarify a public record or counterparty signal.

Source-list verification
Banking and counterparty exposure memo
Regulatory status and remediation triage
Request Risk Assessment
Confidential Review
Export PDFSubscriber Only